NZ249041A - Use of brofaromine(4-(7-bromo-5-methoxy-2-benzofuranyl)-piperdine) for treating post-traumatic stress disorder - Google Patents

Use of brofaromine(4-(7-bromo-5-methoxy-2-benzofuranyl)-piperdine) for treating post-traumatic stress disorder

Info

Publication number
NZ249041A
NZ249041A NZ249041A NZ24904193A NZ249041A NZ 249041 A NZ249041 A NZ 249041A NZ 249041 A NZ249041 A NZ 249041A NZ 24904193 A NZ24904193 A NZ 24904193A NZ 249041 A NZ249041 A NZ 249041A
Authority
NZ
New Zealand
Prior art keywords
brofaromine
active ingredient
medicament
sieve
added
Prior art date
Application number
NZ249041A
Other languages
English (en)
Inventor
Richard Katz
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ249041A publication Critical patent/NZ249041A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NZ249041A 1992-02-21 1993-01-27 Use of brofaromine(4-(7-bromo-5-methoxy-2-benzofuranyl)-piperdine) for treating post-traumatic stress disorder NZ249041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83963992A 1992-02-21 1992-02-21

Publications (1)

Publication Number Publication Date
NZ249041A true NZ249041A (en) 1997-07-27

Family

ID=25280288

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ249041A NZ249041A (en) 1992-02-21 1993-01-27 Use of brofaromine(4-(7-bromo-5-methoxy-2-benzofuranyl)-piperdine) for treating post-traumatic stress disorder

Country Status (7)

Country Link
EP (1) EP0626849A1 (fr)
JP (1) JPH07503972A (fr)
KR (1) KR950700063A (fr)
AU (1) AU676672B2 (fr)
CA (1) CA2117430A1 (fr)
NZ (1) NZ249041A (fr)
WO (1) WO1993016695A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003701A1 (fr) * 1998-07-16 2000-01-27 Massachusetts Institute Of Technology Composition pour le traitement du stress
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
AU7787100A (en) * 1999-10-12 2001-04-23 Connex Gesellschaft Zur Optimierung Von Forschung Und Entwicklung Mbh Improved method for the detection of acid resistant microorganisms in a stool

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH592656A5 (fr) * 1973-03-02 1977-10-31 Ciba Geigy Ag
WO1993016696A1 (fr) * 1992-02-21 1993-09-02 Ciba-Geigy Ag Utilisation de la brofaromine comme agent de traitement de la nevrose phobique

Also Published As

Publication number Publication date
KR950700063A (ko) 1995-01-16
EP0626849A1 (fr) 1994-12-07
CA2117430A1 (fr) 1993-09-02
WO1993016695A1 (fr) 1993-09-02
JPH07503972A (ja) 1995-04-27
AU3484493A (en) 1993-09-13
AU676672B2 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
DE60021266T2 (de) Verwendungen von Zusammensetzungen zur Behandlung oder Vorbeugung von Schlafstörungen unter Verwendung von sehr niedrigen Dosen von Cyclobenzaprin
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
Hartshorn et al. Adverse effects and drug interactions associated with fluoxetine therapy
JPH0920666A (ja) 成熟遅延および類似疾患の治療用医薬組成物
AU2002258820B2 (en) Treatment of disorders secondary to organic impairments
EP1513533B1 (fr) Combinaison d'agents actifs pharmaceutiques et utilisation
AU2002258820A1 (en) Treatment of disorders secondary to organic impairments
NZ249041A (en) Use of brofaromine(4-(7-bromo-5-methoxy-2-benzofuranyl)-piperdine) for treating post-traumatic stress disorder
US20190224208A1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
US5905086A (en) Remedy for anxiety neurosis
DE69910600T2 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
TWI289060B (en) Pharmaceutical composition for improving the recovery of post-stroke patients
CN102038669A (zh) 阿戈美拉汀在获得用于治疗双相性精神障碍的药物中的用途
UA76254C2 (en) Use of desoxypeganine for treating clinical depression
WO1993016696A1 (fr) Utilisation de la brofaromine comme agent de traitement de la nevrose phobique
US10265300B2 (en) Methods of treating seizure disorders
WO2009147831A1 (fr) Procédé et composition pharmaceutique pour le traitement de troubles mentaux
JPH1036258A (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
JPH0317016A (ja) 神経系症状の処置剤
WO2005097138A2 (fr) Combinaisons comprenant de l'oxcarbazepine pour le traitement de troubles affectifs
JPH10287568A (ja) アルコール依存症治療剤
DE10310396A1 (de) Verwendung von Antihistaminika sowie pharmazeutische Wirkstoffkombination